MPO and lung cancer: Moreover, clinical relevance was supported by findings that PMN-MDSCs from lung cancer patients exhibited increased migration and NETosis in response to C5a, with elevated levels of myeloperoxidase (MPO)-DNA complexes—a hallmark of NETosis—correlating with C5a levels in these patients.